- This event has passed.
Taking it to Heart: Addressing Cardiovascular Disease in Women
February 13 @ 1:00 pm - 1:45 pm EST
Diagnostic tests and procedures offer opportunities to detect diseases, monitor disease progression, guide treatments, and evaluate treatment effectiveness. Some diagnostic tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.
Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively, differently, or disproportionately affect women is invaluable in furthering women’s health across sectors.
SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discuss how to improve health outcomes for diseases and conditions that disproportionately or differently affect women, with special a focus on cancer and healthy aging.
The 2023 SWHR Value of Diagnostics within Women’s Health series includes:
- Taking it to Heart: Addressing Cardiovascular Disease in Women (February, 13, 2023)
- Putting our Heads Together: Diagnostic Innovations for Alzheimer’s Disease (June 6, 2023)
- Clearing the Air About Lung Cancer in Women (November 17, 2023)
Follow the conversation on Twitter at @SWHR and #SWHRtalksDiagnostics.
This event is free and open to the public.
Goals
- Discuss the impacts of cardiovascular disease on women’s health, including disparities in disease burden, mortality, and access to care
- Provide an overview of key diagnostic considerations and disease management in women
- Emphasize ways to empower women to adopt healthy habits that may prevent heart disease or improve cardiovascular outcomes
- Highlight health care policies that present barriers to access to quality care and coverage
Panelists
Nieca Goldberg, MD
Nieca Goldberg, MD
Dr. Nieca Goldberg is Medical Director of Atria New York City and Clinical Associate Professor of medicine at NYU Grossman School of Medicine. She was the Co-Medical Director of the 92nd Street Y’s Cardio Rehab Program. Dr. Goldberg is a cardiologist, author, and podcast host of “Beyond the Heart – Improving Your Health One Conversation at a Time,” and a nationally recognized pioneer in women’s heart health. Dr. Goldberg is a national spokesperson for the American Heart Association and started the “Go Red for Women” campaign. Before joining Atria New York City, she was medical director of NYU Women’s Heart Program, Senior Advisor of Women’s Health Strategy NYU Langone Health, the founder, and Medical Director of the Joan H. Tisch Center for Women’s Health at the NYU Langone Medical Center.
Jennifer L. Hall, PhD
Jennifer L. Hall, PhD
Jennifer Hall, PhD serves as the Chief of Data Science and Analytics at the American Heart Association (AHA). Dr. Hall is also an adjunct Professor in the Dept of Medicine at the University of Minnesota. Under her leadership at the AHA, she has established the AHA Precision Medicine Platform, a cloud-based resource for researchers with a web portal providing access to data and workspaces equipped with analysis tools. Dr. Hall’s team works in partnership with NIH and its cloud-based platforms to standardize best practices and interfaces to allow academic researchers agility and ease use of use. She currently serves as a co-PI of the NHGRI’s AnVIL (Analysis, Visualization, and Informatics Lab Space), the goal of which is to create a cloud-based platform for clinicians to have access to genomic information and tools to better treat patients. Dr. Hall lead a team of over 20 data scientists, evaluation analysts and computational engineers. Their evaluation analysts have played a key role in the current AnVIL grant to evaluate the needs of clinical genomics researchers and translate these needs into new tools and resources on the AnVIL platform by working alongside the product teams. Dr. Hall also serves as a co-PI of a data harmonization grant (1R61NS120246-01) in which her team is testing novel harmonization methods with five longitudinal NIH datasets and establish a risk score analysis for stroke. They use the Precision Medicine Platform to provide a portal and search for the metadata to the general public.
Explore previous topics from SWHR’s Value of Diagnostics within Women’s Health Series
Sponsor
SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains independence and editorial control over program development, content, and work products.
